Metsera’s GLP-1 peptide has a protracted half-life, that means it could possibly be administered as soon as a month. The corporate is able to scale up…
Read More
发布者:Dave Vellante and Rob Strechay,转转请注明出处:https://robotalks.cn/why-this-newly-public-biotech-could-become-a-force-in-obesity-treatments/